Ownership history in MARSHALL WACE, LLP · 7 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in INSTIL BIO INC (TIL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 44,878 | +22,580 | +101.3% | 0.00% | $802K | $17.86 |
| 2025 Q1 | REDUCED | 22,298 | -1,400 | -5.9% | 0.00% | $387K | $17.36 |
| 2024 Q4 | ADDED | 23,698 | +272 | +1.2% | 0.00% | $452K | $19.09 |
| 2024 Q3 | REDUCED | 23,426 | -37,200 | -61.4% | 0.00% | $1.6M | $67.32 |
| 2024 Q2 | UNCHANGED | 60,626 | — | 0% | 0.00% | $624K | $10.29 |
| 2024 Q1 | UNCHANGED | 60,626 | — | 0% | 0.00% | $655K | $10.80 |
| 2023 Q4 | INITIATED | 60,626 | — | — | 0.00% | $462K | — |
As of 2025 Q4 — sorted by position size